Literature DB >> 26112463

DOTAP/DOPE ratio and cell type determine transfection efficiency with DOTAP-liposomes.

Bieong-Kil Kim1, Guen-Bae Hwang2, Young-Bae Seu2, Jong-Soo Choi2, Kyeong Sik Jin3, Kyung-Oh Doh4.   

Abstract

The effects of lipid compositions on their physicochemical properties and transfection efficiencies were investigated. Four liposome formulations with different 1,2-dioleoyl-3-trimethylammoniumpropane (DOTAP) to dioleoylphosphatidylethanolamine (DOPE) weight ratios were investigated, that is, weight ratios 1:0 (T1P0), 3:1 (T3P1), 1:1 (T1P1), and 1:3 (T1P3). Mean sizes of liposomes were influenced by their lipid composition and the preparation concentration at the time of sonication. Zeta potentials of liposomes were inversely correlated with their liposome sizes. However, neither liposome sizes nor zeta potentials were correlated with transfection efficiency. The optimum composition of liposomes was cell-line dependent (T1P0 and T3P1 for Huh7 and AGS, T3P1 and T1P1 for COS7, and T1P1 and T1P3 for A549). The shape of lipoplexes was changed from lamellar to inverted hexagonal structure according to the increased ratio of DOPE, but there was no definite advantage of specific structure in transfection efficiency throughout all used cell lines. However, cellular internalization was consistently faster in T1P0, T3P1, T1P1 compared to T1P3 in all cell lines, suggesting the importance of endosomal escape. Our findings show that the transfection efficiency of DOTAP liposomes is mainly influenced by lipid composition and cell type, and not by size or zeta potential.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Gene therapy; Liposomes; Transfection

Mesh:

Substances:

Year:  2015        PMID: 26112463     DOI: 10.1016/j.bbamem.2015.06.020

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  20 in total

Review 1.  Engineering liposomal nanoparticles for targeted gene therapy.

Authors:  C Zylberberg; K Gaskill; S Pasley; S Matosevic
Journal:  Gene Ther       Date:  2017-05-15       Impact factor: 5.250

Review 2.  Liposomal delivery of CRISPR/Cas9.

Authors:  Shuai Zhen; Xu Li
Journal:  Cancer Gene Ther       Date:  2019-11-02       Impact factor: 5.987

Review 3.  Progress of cationic gene delivery reagents for non-viral vector.

Authors:  Kai Ma; Chun-Liu Mi; Xiang-Xiang Cao; Tian-Yun Wang
Journal:  Appl Microbiol Biotechnol       Date:  2021-01-04       Impact factor: 4.813

Review 4.  New methods in the diagnosis of cancer and gene therapy of cancer based on nanoparticles.

Authors:  M A Zaimy; N Saffarzadeh; A Mohammadi; H Pourghadamyari; P Izadi; A Sarli; L K Moghaddam; S R Paschepari; H Azizi; S Torkamandi; J Tavakkoly-Bazzaz
Journal:  Cancer Gene Ther       Date:  2017-06-02       Impact factor: 5.987

5.  In vitro and in vivo optimization of liposomal nanoparticles based brain targeted vgf gene therapy.

Authors:  Sanjay Arora; Jagdish Singh
Journal:  Int J Pharm       Date:  2021-09-20       Impact factor: 5.875

6.  Ionizable Lipid Nanoparticle-Mediated Delivery of Plasmid DNA in Cardiomyocytes.

Authors:  Sérgio Scalzo; Anderson K Santos; Heloísa A S Ferreira; Pedro A Costa; Pedro H D M Prazeres; Natália J A da Silva; Lays C Guimarães; Mário de Morais E Silva; Marco T R Rodrigues Alves; Celso T R Viana; Itamar C G Jesus; Alice P Rodrigues; Alexander Birbrair; Anderson O Lobo; Frederic Frezard; Michael J Mitchell; Silvia Guatimosim; Pedro Pires Goulart Guimaraes
Journal:  Int J Nanomedicine       Date:  2022-06-30

7.  CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice.

Authors:  Anvar Soleimani; Farshad Mirzavi; Sara Nikoofal-Sahlabadi; Amin Reza Nikpoor; Bita Taghizadeh; Mehdi Barati; Mohammad Soukhtanloo; Mahmoud Reza Jaafari
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

8.  Fluorescence-coded DNA Nanostructure Probe System to Enable Discrimination of Tumor Heterogeneity via a Screening of Dual Intracellular microRNA Signatures in situ.

Authors:  Seung Won Shin; Byoung Sang Lee; Kisuk Yang; Lunjakorn Amornkitbamrung; Min Su Jang; Bo Mi Ku; Seung-Woo Cho; Jung Heon Lee; Hojae Bae; Byung-Keun Oh; Myung-Ju Ahn; Yong Taik Lim; Soong Ho Um
Journal:  Sci Rep       Date:  2017-10-18       Impact factor: 4.379

9.  Anticancer Activities of Ricin-Liposome Complexes on SKMEL-28 Cells.

Authors:  Nguyen Thi Bich Loan; Ngo Ngoc Trung; Nguyen Thi Le Na; Nguyen Dinh Thang
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

10.  Gene delivery into hepatic cells with ternary complexes of plasmid DNA, cationic liposomes and apolipoprotein E-derived peptide.

Authors:  Yoshiyuki Hattori; Yuta Nakagawa; Hiraku Onishi
Journal:  Exp Ther Med       Date:  2019-08-07       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.